Overview
Study of A3309 in Patients With Dyslipidemia
Status:
Completed
Completed
Trial end date:
2010-09-01
2010-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with dyslipidemia (high cholesterol levels).Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Albireo
Criteria
Inclusion Criteria:- Patients meet protocol specified criteria for dyslipidemia and has successfully
completed study requirements with no clinically relevant findings
Exclusion Criteria:
- Medical history or medical condition that would not make the patient a good candidate
for the study or would limit the patient´s capability to complete the study